EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
Slovenia flag Slovenia · Delayed Price · Currency is EUR
63.00
0.00 (0.00%)
At close: Jul 30, 2025

Orchard Therapeutics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1.31.070.870.710.54
Depreciation & Amortization
3.933.933.763.413.43
Change in Accounts Receivable
0.2-0.42-0.350.0115.01
Change in Other Net Operating Assets
0.130.320.223.47-0.3
Other Operating Activities
1.220.991.070.64-3.64
Operating Cash Flow
7.026.365.78.2914.87
Operating Cash Flow Growth
17.40%11.45%-31.19%-44.24%-
Acquisition of Real Estate Assets
-2.32-3.51-2.25-5.75-0.23
Sale of Real Estate Assets
0.30.30.14--
Net Sale / Acq. of Real Estate Assets
-2.02-3.21-2.11-5.75-0.23
Investment in Marketable & Equity Securities
-3.66-3.73-3.081.04-8.17
Other Investing Activities
1.421.421.180.30.08
Investing Cash Flow
-4.26-5.52-4.01-4.42-8.33
Long-Term Debt Issued
-0.623.889.98-
Long-Term Debt Repaid
--1.28-9.63-9.38-
Total Debt Repaid
7.19-1.28-9.63-9.38-0.38
Net Debt Issued (Repaid)
1.28-0.66-5.750.6-0.38
Common Dividends Paid
-3.17-3.02-2.57--
Other Financing Activities
-0.45-0.45-0.53-0.36-0.16
Miscellaneous Cash Flow Adjustments
0---4.05
Net Cash Flow
0.43-3.3-7.154.1110.05
Cash Interest Paid
0.450.450.530.360.16
Cash Income Tax Paid
0.220.220.150.06-
Levered Free Cash Flow
5.323.493.443.67-
Unlevered Free Cash Flow
5.623.813.844.2-
Change in Net Working Capital
-0.940.310.16-0.07-
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.